logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12186292 B1

PDFFull Text
Date of Patent:
Jan. 07, 2025

Filed:

Dec. 15, 2022

Benefits of supplementation with n-acetylcysteine and glycine to improve glutathione levels

Applicants:

Société Des Produits Nestlé S.a., Vevey, CH;

Baylor College of Medicine, Houston, TX (US);

Inventors:

Stephen Kirnon, San Ramon, CA (US);

Eric Freedland, Marblehead, MA (US);

Rajagopal V. Sekhar, Missouri City, TX (US);

Assignees:

Societe des Produits Nestle S.A., Vevey, CH;

Baylor College of Medicine, Houston, TX (US);

Attorney:

K&L Gates LLP

Primary Examiner:

Jeffrey E Russel

Int. Cl.
CPC ...
A61K 31/155 (2006.01); A23K 20/142 (2016.01); A23K 50/50 (2016.01); A61K 31/167 (2006.01); A61K 31/198 (2006.01); A61K 31/205 (2006.01); A61K 31/223 (2006.01); A61K 31/27 (2006.01); A61K 31/341 (2006.01); A61K 31/381 (2006.01); A61K 31/683 (2006.01); A61K 38/02 (2006.01); A61K 38/05 (2006.01); A61K 38/21 (2006.01); A61K 45/06 (2006.01); A61P 21/00 (2006.01); A61P 29/00 (2006.01); A61P 31/18 (2006.01); A61P 39/00 (2006.01); A61P 39/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/198 (2013.01); A23K 20/142 (2016.05); A23K 50/50 (2016.05); A61K 31/155 (2013.01); A61K 31/167 (2013.01); A61K 31/205 (2013.01); A61K 31/223 (2013.01); A61K 31/27 (2013.01); A61K 31/341 (2013.01); A61K 31/381 (2013.01); A61K 31/683 (2013.01); A61K 38/02 (2013.01); A61K 38/05 (2013.01); A61K 38/21 (2013.01); A61K 45/06 (2013.01); A61P 21/00 (2018.01); A61P 29/00 (2018.01); A61P 31/18 (2018.01); A61P 39/00 (2018.01); A61P 39/06 (2018.01);
Abstract

A method of neutralizing or mitigating a drug-induced mitochondrial dysfunction or impairment for an individual, the method including providing to the individual an effective amount of a composition containing glycine or a functional derivative thereof and N-acetylcysteine or a functional derivative thereof. The drug-induced mitochondrial dysfunction or impairment is from at least one drug consumed by the individual selected from the group consisting of an anticonvulsant; a psychotropic other than an antipsychotic drug; an analgesic/anti-inflammatory drug other than acetaminophen; an antibiotic; an anti-arrhythmic drug; a steroid; a beta-blocker; and an immunization.

Find Patent Forward Citations

Loading…